Transgenomic (TBIO) Reports Q1 Loss Per Share of $0.36
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Transgenomic Reports First Quarter 2015 Financial Results
May 14, 2015 4:05 PM EDTConference Call to Be Held at 5:00 PM Eastern Time Today
OMAHA, Neb.--(BUSINESS WIRE)-- Transgenomic, Inc. (NASDAQ: TBIO) today reported financial results for the first quarter ended March 31, 2015, and provided a business update.
First Quarter Financial ResultsNet sales for the first quarter of 2015 were $6.5 million, a 4% increase as compared with $6.3 million for the same period in 2014. Excluding the impact of the divested Surveyor product line, year-over-year net sales increased approximately 11%. First quarter 2015 Laboratory Services segment sales increased by $1.2 million, or 32%, from the same period in 2014,... More
